Search - tctmd.com

Displaying 241 - 260 of 532

Sort: Relevancy | Date

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Daily News

接受 TAVR 的年满 90 岁患者死亡风险“临床适度”增加

March 23, 2016

News Daily News

Se Observa un ‘Tímido Aumento Clínico’ del Riesgo de Mortalidad en Nonagenarios sometidos a TAVR

March 23, 2016

News Daily News

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Michael O'Riordan

March 14, 2016

News Daily News

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Michael O'Riordan

March 14, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Daily News

第 12 个月时女性的经导管主动脉瓣结局优于男性

Shelley Wood

February 23, 2016

News Daily News

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

Shelley Wood

February 23, 2016

News Industry News

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

February 21, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Daily News

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Michael O'Riordan

February 08, 2016

News Daily News

TAVR 后房颤尤其是新发房颤与死亡风险升高有关

Michael O'Riordan

January 18, 2016

News Daily News

El Diagnóstico de FA Post-TAVR sobre todo de Nueva Aparición se asocia a un Mayor Riesgo de Mortalidad

Michael O'Riordan

January 18, 2016

News Daily News

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

Michael O'Riordan

January 18, 2016

News Daily News

FDA Grants Go-Ahead for Low-Risk TAVR Study

Shelley Wood

January 14, 2016

News Industry News

Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve

January 14, 2016

Presentation

A-fib Associated With Increased Mortality in Patients Undergoing TAVR: PARTNER Analysis

Presenter: Angelo Biviano

January 07, 2016

News Daily News

低流量、低跨瓣压差患者死亡率较高，接受 AVR 可能性较低

L.A. McKeown

December 07, 2015

News Daily News

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

L.A. McKeown

December 07, 2015

Advertisement

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

接受 TAVR 的年满 90 岁患者死亡风险“临床适度”增加

Se Observa un ‘Tímido Aumento Clínico’ del Riesgo de Mortalidad en Nonagenarios sometidos a TAVR

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

第 12 个月时女性的经导管主动脉瓣结局优于男性

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

TAVR 后房颤尤其是新发房颤与死亡风险升高有关

El Diagnóstico de FA Post-TAVR sobre todo de Nueva Aparición se asocia a un Mayor Riesgo de Mortalidad

A-Fib Diagnosis After TAVR, Particularly When New-Onset, Associated With Higher Risk of Mortality

FDA Grants Go-Ahead for Low-Risk TAVR Study

Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve

A-fib Associated With Increased Mortality in Patients Undergoing TAVR: PARTNER Analysis

低流量、低跨瓣压差患者死亡率较高，接受 AVR 可能性较低

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content